NASA may have just taken a major step toward sending humans to Mars. 🚀

NASA’s next-generation lithium ion engine could change the future of Mars exploration forever.

Scientists at NASA’s Jet Propulsion Laboratory successfully tested a powerful new lithium-fed ion engine capable of reaching power levels never before achieved in the United States. The experimental electromagnetic thruster generated 120 kilowatts of power — around 25 times stronger than the ion engines currently used on NASA spacecraft.

Unlike traditional chemical rockets, ion propulsion systems use electromagnetic fields to accelerate charged particles, allowing spacecraft to travel farther while using far less fuel. Researchers believe this technology, especially when combined with future nuclear-powered space systems, could make long-duration human missions to Mars far more practical and cost-effective.

The glowing plasma engine reached temperatures hotter than molten lava during testing, highlighting both the incredible engineering challenge and the exciting future of deep-space travel.

NASA hopes to scale the technology even further in the coming years, potentially creating megawatt-class propulsion systems capable of carrying astronauts across the solar system.

Croatian Rhapsody - maksim

Vivaldi Techno Waves 🌌 Atmospheric Melodic Techno for Focus & Relaxation - Tolelodang

Stock Market Today is sending mixed signals that every investor should understand.

Stock Market Today: Hidden risks at record highs, Docusign’s valuation warning, and Netflix’s mixed signals

While markets are hitting record highs, not all sectors are behaving the same. Data shows that tech-heavy and small-cap indexes like the Nasdaq and Russell 2000 may actually deliver weaker returns after peaks compared to normal periods—challenging a common investing myth.

At the same time, Docusign looks cheap on the surface, but deeper analysis reveals hidden costs that could trap investors. Meanwhile, Netflix is attracting massive institutional interest and beating earnings expectations, yet cautious guidance and insider selling are keeping sentiment divided.

This is a market where surface-level analysis is no longer enough. Smart investors are digging deeper, staying disciplined, and adapting strategies to navigate uncertainty.

Cancer research is entering a new era of real breakthroughs.

New cancer breakthroughs: targeted therapies, AI detection, and a new future in oncology.

A new targeted drug called daraxonrasib is showing the ability to nearly double survival time in pancreatic cancer patients by directly attacking the KRAS mutation responsible for tumor growth. For a disease that is often diagnosed late and has a very low survival rate, this represents a major step forward.

At the same time, artificial intelligence is transforming how we detect and understand cancer. From identifying tumors earlier than human doctors can see, to predicting how cancer spreads with high accuracy, AI is becoming a powerful tool in modern medicine.

These innovations are not cures yet—but they are reshaping what is possible in cancer care and giving patients more time, better treatment options, and new hope for the future.